US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
RV

RVTY

Revvity, Inc.
$120.94-2.35% today
Tracked investors holding RVTY
InvestorFirmPositionWeightAs of
Ray Dalio Bridgewater Associates $3M 0.0% 2026-06-30
Ken Fisher Fisher Asset Management $1M 0.0% 2026-06-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25
🕌 Held by MNZL HTR non-permissible income 1.09%
Methodology breakdown (7/7 compliant)▾
AAOIFI ● PASS ▾
Debt ratio 23.1% (< 30%)
Investments ratio 7.0% (< 30%)
Non permissible income ratio 1.1% (< 5%)
Usmani ● PASS ▾
Debt ratio 27.9% (< 33%)
Investments ratio 8.5% (< 33%)
Nonliquid assets ratio 85.6% (< 20%)
Non permissible income ratio 1.1% (< 5%)
Net liquid assets $0.5B (mkt cap $14.5B)
Dow Jones ● PASS ▾
Debt ratio 27.9% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 5.9% (< 33%)
Non permissible income ratio 1.1% (< 5%)
S&P Shariah ● PASS ▾
Debt ratio 27.2% (< 33%)
Cash and interest ratio 8.3% (< 49%)
Receivables ratio 5.7% (< 49%)
Non permissible income ratio 1.1% (< 5%)
MSCI ● PASS ▾
Debt ratio 27.9% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 14.4% (< 33%)
Non permissible income ratio 1.1% (< 5%)
MSCI M ● PASS ▾
Debt ratio 27.2% (< 33%)
Cash and interest ratio 8.3% (< 33%)
Receivables ratio 14.0% (< 49%)
Non permissible income ratio 1.1% (< 5%)
FTSE ● PASS ▾
Debt ratio 26.7% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 14.4% (< 50%)
Non permissible income ratio 1.1% (< 5%)

Business activity cleared — no excluded categories detected

🔎 Data provenance — sourcing & safeguards behind these numbers

Source: stored filing inputs · Balance sheet as of 2026-07-05 · Income statement as of 2025-12-28

Real XBRL tags pulled from the issuer's own filing:
Total assets Assets
Debt DebtLongtermAndShorttermCombinedAmount
Total liabilities Liabilities
Lease liabilities OperatingLeaseLiabilityNoncurrent
Operating lease liabilities OperatingLeaseLiabilityNoncurrent
Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Current liabilities LiabilitiesCurrent
Receivables AccountsReceivableNetCurrent
Total revenue RevenueFromContractWithCustomerExcludingAssessedTax
Interest income InvestmentIncomeInterest
Finance costs InterestExpense
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
80
of 100
Setup confidence — system conviction, not win probabilityA
Why this signal?
Structure0 of 5 timeframes bullish · 100.0% aligned
VWAPPrice below VWAP ($126.79)
VolumeRelative volume 3.8× the 20-day average
Momentum10-day rate of change -3.3%
Overall readNEUTRAL — No Edge

Revvity, Inc. (RVTY) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$126.12
+4.3% · 17 analysts
Institutional own.
96.5%
of shares
Momentum (10d)
-3.3%
rate of change
SMC grade
A · 80
100.0% aligned
COMPLIANT
Sharia compliance
🕌 MNZL
Held by real halal ETF(s)
1.09%
Non-permissible income — HTR, from filings (2025-12-28)
A · 80
SMC grade — 100.0% timeframe alignment
-3.3%
Rate of change (10d)
$126.12
Price target (+4.3%) · 17 analysts
96.5%
Institutional ownership

🕌 In-house Compliance Research

Research only, not the primary verdict above — computed from SEC EDGAR filings and business-activity classification, same as the Discord bot's !halal command.

Business activity: cleared (no excluded categories detected)

AAOIFI Standard 21 (% of market cap) — Pass
Debt ratio 23.1% (< 30%)
Investments ratio 7.0% (< 30%)
Non permissible income ratio 1.1% (< 5%)
Usmani (% of total assets) — Pass
Debt ratio 27.9% (< 33%)
Investments ratio 8.5% (< 33%)
Nonliquid assets ratio 85.6% (< 20%)
Non permissible income ratio 1.1% (< 5%)
Net liquid assets $0.5B (mkt cap $14.5B)
Dow Jones Islamic Market (% of 24-mo avg market cap) — Pass
Debt ratio 27.9% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 5.9% (< 33%)
Non permissible income ratio 1.1% (< 5%)
S&P Shariah Indices (% of 36-mo avg market cap) — Pass
Debt ratio 27.2% (< 33%)
Cash and interest ratio 8.3% (< 49%)
Receivables ratio 5.7% (< 49%)
Non permissible income ratio 1.1% (< 5%)
MSCI Islamic Index (% of total assets) — Pass
Debt ratio 27.9% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 14.4% (< 33%)
Non permissible income ratio 1.1% (< 5%)
MSCI Islamic M-Series (% of 36-mo avg market cap) — Pass
Debt ratio 27.2% (< 33%)
Cash and interest ratio 8.3% (< 33%)
Receivables ratio 14.0% (< 49%)
Non permissible income ratio 1.1% (< 5%)
FTSE Shariah Global Equity Index Series (% of total assets) — Pass
Debt ratio 26.7% (< 33%)
Cash and interest ratio 8.5% (< 33%)
Receivables ratio 14.4% (< 50%)
Non permissible income ratio 1.1% (< 5%)
🔎 Data provenance — sourcing & safeguards behind these numbers

Source: stored filing inputs · Balance sheet as of 2026-07-05 · Income statement as of 2025-12-28

↳ Operating lease liabilities ($0.1B) folded into the debt figure above, per AAOIFI's post-IFRS-16 treatment.
Real XBRL tags pulled from the issuer's own filing (auditable against it directly):
Total assets Assets
Debt DebtLongtermAndShorttermCombinedAmount
Total liabilities Liabilities
Lease liabilities OperatingLeaseLiabilityNoncurrent
Operating lease liabilities OperatingLeaseLiabilityNoncurrent
Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Current liabilities LiabilitiesCurrent
Receivables AccountsReceivableNetCurrent
Total revenue RevenueFromContractWithCustomerExcludingAssessedTax
Interest income InvestmentIncomeInterest
Finance costs InterestExpense

Combined verdict: AAOIFI Compliant Usmani Compliant Dow Jones Islamic Compliant S&P Shariah Compliant MSCI Islamic Compliant MSCI Islamic M Compliant FTSE Shariah Compliant

130.94118.76106.5794.3982.212025-09-112026-03-122026-09-10

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
115.69
S2
118.44
S1
121.15
PIVOT
123.90
R1
126.61
R2
129.36
R3
132.07

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
120.284 – 140.376
±7.71% from 130.33, made 2026-09-02 · resolves 2026-09-09
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21887 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)47.30NEUTRAL
Stochastic %K (14)0.33BUY
CCI (20)-35.82NEUTRAL
Williams %R (14)-99.67BUY
MACD (12,26,9)-0.86SELL
ROC (10)-4.28SELL
Momentum (10)-5.41SELL
EMA (10)125.79SELL
SMA (10)127.74SELL
EMA (20)123.99SELL
SMA (20)124.21SELL
EMA (30)121.73SELL
SMA (30)121.01SELL
EMA (50)117.72BUY
SMA (50)117.11BUY
EMA (100)110.87BUY
SMA (100)107.37BUY
EMA (200)104.76BUY
SMA (200)102.73BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Revvity, Inc.

Healthcare · Diagnostics & Research

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

revvity.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

⚪ NEUTRAL — No Edge

Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.

Scores: 2 bullish / 2 bearish

Grade verdict

Strong setup, well-confirmed

SMC — Top Down

TimeframeBiasBars
📅 Daily BEARISH 62
⏰ 4H BEARISH 37
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

3.06
MACD (no fresh cross)

Insider Activity (90d)

BEARISH   0 buys · 1 sells

Recent: Gonzales Anita sold 7201 sh @ $109.48 (2026-07-20)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

Key Statistics

$81.22 – $133.00
52-week range
50
RSI
4/10
Risk score

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.